Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

Cardinal Health, Inc. operates as a healthcare services ... providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including ...

Sen. Tammy Baldwin visited UW-Madison to hear how federal funding helps combat the fentanyl crisis in Wisconsin as President ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on Walgreens Boots Alliance (WBA – Research Report), with a ...

As the new Trump administration targets transgender individuals, families are protecting themselves in any way they can.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Walgreens Boots Alliance (WBA – Research ...

Cardinal Health, Inc. (NYSE:CAH) is one of the biggest healthcare service providers in the US. The firm caters to the needs of the hospital, pharmacy, and other associated healthcare industries.